You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 3, March 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Treatment of Posttraumatic Stress Disorder With Amitriptyline and Placebo

Jonathan Davidson, MD; Harold Kudler, MD; Rebecca Smith, RN; Steven L. Mahorney, MD; Steven Lipper, MD, PhD; Elliott Hammett, MD; William B. Saunders, MPH; Jesse O. Cavenar, Jr, MD

Arch Gen Psychiatry. 1990;47(3):259-266.


Abstract

• Amitriptyline hydrochloride was compared with placebo in 46 veterans with chronic posttraumatic stress disorder. Treatment continued up to 8 weeks, and efficacy was measured by five observer and two self-rated scales. Percent recovery rates were higher for amitriptyline than placebo on two measures. In patients who completed 4 weeks (n = 40), better outcome with amitriptyline was noted on the Hamilton depression scale only. In the group completing 8 weeks of treatment (n = 33), the drug was superior to placebo on Hamilton depression, Hamilton anxiety, Clinical Global Impression severity, and Impact of Event scales. There was no evidence for drug effects on the structured interview for posttraumatic stress disorder. Drug-placebo differences were greater in the presence of comorbidity in general, although recovery rates were uniformly low in the presence of major depression, panic disorder, and alcoholism. At the end of treatment, 64% of the amitriptyline and 72% of the placebo samples still met diagnostic criteria for posttraumatic stress disorder.



Author Affiliations

From the Duke University Medical Center (Drs Davidson, Kudler, Mahorney, Lipper, and Hammett, Ms Smith, and Mr Saunders) and the Veterans Administration Medical Center (Drs Kudler, Mahorney, Lipper, Hammett, and Cavenar), Durham, NC.


Footnotes

Accepted for publication February 3, 1989.

Reprint requests to Duke University Medical Center, Box 3812, Durham, NC 27710 (Dr Davidson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis and Management of Posttraumatic Stress Disorder in Returning Veterans
Reeves
JAOA: Journal of the American Osteopathic Association 2007;107:181-189.
ABSTRACT | FULL TEXT  

Pharmacological treatment of post-traumatic stress disorder
Bisson
Adv. Psychiatr. Treat. 2007;13:119-126.
ABSTRACT | FULL TEXT  

Current Concepts in Pharmacotherapy for Posttraumatic Stress Disorder
Schoenfeld et al.
Psychiatr. Serv. 2004;55:519-531.
ABSTRACT | FULL TEXT  

Posttraumatic Stress Disorder: Acquisition, Recognition, Course, and Treatment
Davidson et al.
J. Neuropsychiatry Clin. Neurosi. 2004;16:135-147.
ABSTRACT | FULL TEXT  

Prescribing Patterns for Patients With Posttraumatic Stress Disorder
Mellman et al.
Psychiatr. Serv. 2003;54:1618-1621.
ABSTRACT | FULL TEXT  

Posttraumatic Stress Disorder
Connor and Butterfield
Focus 2003;1:247-262.
ABSTRACT | FULL TEXT  

Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study
Davidson et al.
Focus 2003;1:273-281.
ABSTRACT | FULL TEXT  

Repetitive Transcranial Magnetic Stimulation Treatment of Comorbid Posttraumatic Stress Disorder and Major Depression
Rosenberg et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:270-276.
ABSTRACT | FULL TEXT  

A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Posternak et al.
Am. J. Psychiatry 2002;159:191-200.
ABSTRACT | FULL TEXT  

Post-Traumatic Stress Disorder
Yehuda
NEJM 2002;346:108-114.
FULL TEXT  

Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study
Davidson et al.
Am. J. Psychiatry 2001;158:1974-1981.
ABSTRACT | FULL TEXT  

Recognition and Treatment of Posttraumatic Stress Disorder
Davidson
JAMA 2001;286:584-588.
FULL TEXT  

Multicenter, Double-blind Comparison of Sertraline and Placebo in the Treatment of Posttraumatic Stress Disorder
Davidson et al.
Arch Gen Psychiatry 2001;58:485-492.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder: A Randomized Controlled Trial
Brady et al.
JAMA 2000;283:1837-1844.
ABSTRACT | FULL TEXT  

Selective serotonin reuptake inhibitors in post-traumatic stress disorder
Hidalgo and Davidson
J Psychopharmacol 2000;14:70-76.
ABSTRACT  

What do brain imaging studies tell us about anxiety disorders?
Malizia
J Psychopharmacol 1999;13:372-378.
ABSTRACT  

Treatment of Posttraumatic Stress Disorder by Exposure and/or Cognitive Restructuring: A Controlled Study
Marks et al.
Arch Gen Psychiatry 1998;55:317-325.
ABSTRACT | FULL TEXT  

Benzodiazepine receptors and positron emission tomography: ten years of experience. A new beginning?
Malizia and Richardson
J Psychopharmacol 1995;9:355-368.
 

Progress in Psychiatry- Second of Two Parts
Michels and Marzuk
NEJM 1993;329:628-638.
FULL TEXT  

Efficacy of Treatments for Posttraumatic Stress Disorder: An Empirical Review
Solomon et al.
JAMA 1992;268:633-638.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.